Balance Sheet BioArctic AB

Equities

BIOA B

SE0010323311

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 06:43:12 12/05/2026 pm IST			5-day change	1st Jan Change
319.00 ^SEK	-3.10%		-1.17%	+3.60%

08/05	US FDA Extends Review Period for BioArctic's Co-developed Alzheimer's Therapy	MT
08/05	Futures point to negative opening for Stockholm Stock Exchange (update)	FW

5875669f7d556d99f720262.9mzDqzwqBAaD8ThIlBaME8OsuRX9f5FVxhEfuO7SDMg.oS2R53VjbH77s18j-kK-QIb_4Xm4M9UflVNT4ryQQKOzB4zhS3JbVrapdQ

Published financial data: BIOARCTIC AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.31Cr	23Cr	62Cr	26Cr	199.91Cr
Other Revenues, Total	25.17L	11.41L	-	-	-
Total Revenues	2.57Cr	23Cr	62Cr	26Cr	199.91Cr
Cost of Goods Sold, Total	5.51Cr	7.43Cr	8.96Cr	2.7Cr	5.92Cr
Gross Profit	-2.94Cr	16Cr	53Cr	23Cr	193.99Cr
Selling General & Admin Expenses, Total	9.74Cr	15Cr	25Cr	15Cr	19Cr
R&D Expenses	-	-	-	31Cr	38Cr
Depreciation & Amortization - (IS)	1.31Cr	1.46Cr	1.84Cr	-	-
Other Operating Expenses	-9T	-3L	-3L	-	-1L
Other Operating Expenses, Total	11Cr	16Cr	27Cr	46Cr	57Cr
Operating Income	-14Cr	-79.38L	26Cr	-23Cr	136.82Cr
Interest Expense, Total	-8L	-6L	-3L	-	-20.26L
Interest And Investment Income	-	25.35L	3.42Cr	4.08Cr	3.47Cr
Net Interest Expenses	-8L	19.76L	3.39Cr	4.08Cr	3.27Cr
Currency Exchange Gains (Loss)	3L	-50.14L	-1.43Cr	-7L	-14Cr
Other Non Operating Income (Expenses)	-1L	-2L	-50T	1T	-3L
EBT, Excl. Unusual Items	-14Cr	-1.12Cr	28Cr	-19Cr	125.56Cr
Gain (Loss) On Sale Of Assets	-8T	-	-	-	-
EBT, Incl. Unusual Items	-14Cr	-1.12Cr	28Cr	-19Cr	125.56Cr
Income Tax Expense	-2.07Cr	11T	4.72Cr	-1.24Cr	23Cr
Earnings From Continuing Operations	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Net Income to Company	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Net Income - (IS)	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Net Income to Common Incl Extra Items	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Net Income to Common Excl. Extra Items	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Per Share Items
Net EPS - Basic	-1.36	-0.13	2.6	-2	11.55
Basic EPS - Continuing Operations	-1.36	-0.13	2.6	-2	11.55
Basic Weighted Average Shares Outstanding	8.81Cr	8.81Cr	8.82Cr	8.83Cr	8.85Cr
Net EPS - Diluted	-1.36	-0.13	2.59	-2	11.52
Diluted EPS - Continuing Operations	-1.36	-0.13	2.59	-2	11.52
Diluted Weighted Average Shares Outstanding	8.81Cr	8.87Cr	8.85Cr	8.85Cr	8.87Cr
Normalized Basic EPS	-1	-0.08	1.96	-1.34	8.86
Normalized Diluted EPS	-1	-0.08	1.95	-1.34	8.84
Dividend Per Share	-	-	-	-	2
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-13Cr	-17.66L	28Cr	-21Cr	-
EBITA	-14Cr	-79.38L	26Cr	-23Cr	136.82Cr
EBIT	-14Cr	-79.38L	26Cr	-23Cr	136.82Cr
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	2.67Cr	23Cr	-62Cr	-	-
Effective Tax Rate - (Ratio)	14.75	-0.1	17.08	6.56	18.58
Total Current Taxes	-	-	3.48Cr	3L	17Cr
Total Deferred Taxes	-2.07Cr	11T	1.24Cr	-1.28Cr	5.85Cr
Normalized Net Income	-8.78Cr	-69.8L	17Cr	-12Cr	78Cr
Interest on Long-Term Debt	8L	6L	3L	-	20.26L
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	5.55Cr	7.92Cr
General and Administrative Expenses	-	-	-	9.34Cr	12Cr
Research And Development Expense From Footnotes	-	-	-	31Cr	38Cr
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	15.68L	27.6L	1.61Cr	-	-
Stock-Based Comp., Other (Total)	-	-	-	1.93Cr	2.4Cr
Total Stock-Based Compensation	15.68L	27.6L	1.61Cr	1.93Cr	2.4Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	85Cr	81Cr	61Cr	51Cr	104.04Cr
Short Term Investments	-	-	50Cr	27Cr	115Cr
Total Cash And Short Term Investments	85Cr	81Cr	111.16Cr	78Cr	219.04Cr
Accounts Receivable, Total	28.39L	-	2L	7.12Cr	12Cr
Other Receivables	62.05L	79.56L	3.15Cr	14Cr	17Cr
Total Receivables	90.44L	79.56L	3.18Cr	21Cr	29Cr
Prepaid Expenses	43.37L	74.98L	94.02L	1.82Cr	96.15L
Other Current Assets, Total	-	1T	-1T	-	-
Total Current Assets	86Cr	82Cr	115.27Cr	101.07Cr	248.7Cr
Gross Property Plant And Equipment	8.22Cr	9.79Cr	11Cr	16Cr	17Cr
Accumulated Depreciation	-4.85Cr	-6.27Cr	-7.73Cr	-6.17Cr	-8.94Cr
Net Property Plant And Equipment	3.37Cr	3.53Cr	3.11Cr	9.66Cr	8.3Cr
Deferred Tax Assets Long-Term	6L	6L	6L	10L	14.55L
Other Long-Term Assets, Total	15.88L	16.06L	16.48L	34.41L	38.33L
Total Assets	90Cr	86Cr	118.61Cr	111.17Cr	257.52Cr
Liabilities
Accounts Payable, Total	1.18Cr	2.15Cr	2.99Cr	5.05Cr	2.39Cr
Accrued Expenses, Total	1.83Cr	3.51Cr	4.88Cr	6.83Cr	33Cr
Current Portion of Leases	80.92L	88.57L	28.27L	1.31Cr	1.57Cr
Current Income Taxes Payable	-	-	3.38Cr	3.36Cr	14Cr
Unearned Revenue Current, Total	5.91Cr	-	-	-	-
Other Current Liabilities	39.2L	54.27L	96.65L	1.01Cr	1.03Cr
Total Current Liabilities	10Cr	7.09Cr	12Cr	18Cr	52Cr
Long-Term Leases	77.85L	11.82L	21.52L	4.11Cr	2.83Cr
Deferred Tax Liability Non Current	-	-	1.24Cr	-	5.9Cr
Other Non Current Liabilities	1T	1T	-	-	-
Total Liabilities	11Cr	7.21Cr	14Cr	22Cr	61Cr
Common Stock, Total	17.61L	17.63L	17.66L	17.68L	17.73L
Additional Paid In Capital	56Cr	57Cr	58Cr	59Cr	61Cr
Retained Earnings	23Cr	22Cr	46Cr	31Cr	135.14Cr
Comprehensive Income and Other	10L	10L	10L	10L	8L
Total Common Equity	79Cr	79Cr	104.66Cr	89Cr	196.71Cr
Total Equity	79Cr	79Cr	104.66Cr	89Cr	196.71Cr
Total Liabilities And Equity	90Cr	86Cr	118.61Cr	111.17Cr	257.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.81Cr	8.81Cr	8.83Cr	8.84Cr	8.86Cr
ECS Total Common Shares Outstanding	8.81Cr	8.81Cr	8.83Cr	8.84Cr	8.86Cr
Book Value / Share	8.96	8.92	11.85	10.13	22.19
Tangible Book Value	79Cr	79Cr	104.66Cr	89Cr	196.71Cr
Tangible Book Value Per Share	8.96	8.92	11.85	10.13	22.19
Total Debt	1.59Cr	1Cr	49.79L	5.42Cr	4.41Cr
Net Debt	-83Cr	-80Cr	-110.66Cr	-72Cr	-214.64Cr
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.98Cr	5.03Cr	5.71Cr	7.25Cr	8.27Cr
Full Time Employees	49	61	88	107	129

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-12Cr	-1.12Cr	23Cr	-18Cr	102.23Cr
Depreciation & Amortization - CF	1.35Cr	1.42Cr	74.39L	1.07Cr	1.52Cr
Depreciation & Amortization, Total	1.35Cr	1.42Cr	74.39L	1.07Cr	1.52Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Stock-Based Compensation (CF)	15.68L	27.6L	1.61Cr	1.93Cr	2.4Cr
Other Operating Activities, Total	-3.07Cr	-6.23Cr	4.37Cr	-11Cr	20Cr
Change In Accounts Receivable	-51.22L	-24.14L	-1.2Cr	-11Cr	-6.48Cr
Change in Other Net Operating Assets	62T	2.73Cr	2.51Cr	4.27Cr	24Cr
Cash from Operations	-14Cr	-3.16Cr	31Cr	-32Cr	143.11Cr
Capital Expenditure	-43.86L	-1.27Cr	-74.43L	-2.66Cr	-1.02Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-27T	-18T	-50Cr	23Cr	-88Cr
Other Investing Activities, Total	1T	1T	-	1T	-
Cash from Investing	-44.12L	-1.28Cr	-51Cr	21Cr	-89Cr
Long-Term Debt Issued, Total	-	-	-	-	9L
Total Debt Issued	-	-	-	-	9L
Long-Term Debt Repaid, Total	-73.89L	-87.93L	-9L	-3L	-
Total Debt Repaid	-73.89L	-87.93L	-9L	-3L	-
Issuance of Common Stock	-	59.85L	1.5Cr	60.16L	2.6Cr
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-1T	-1T	-
Cash from Financing	-73.89L	-28.08L	1.41Cr	56.86L	2.69Cr
Foreign Exchange Rate Adjustments	7L	41.9L	-1.01Cr	63.74L	-3.58Cr
Miscellaneous Cash Flow Adjustments	1T	-	1T	-	-
Net Change in Cash	-15Cr	-4.3Cr	-19Cr	-9.86Cr	53Cr
Supplemental Items
Cash Interest Paid	10L	8L	4L	18.49L	23.53L
Cash Income Tax Paid (Refund)	3L	-3L	-2L	5L	7.16Cr
Levered Free Cash Flow	-9.06Cr	-3.43Cr	21Cr	-29Cr	116.07Cr
Unlevered Free Cash Flow	-9.01Cr	-3.4Cr	21Cr	-29Cr	116.19Cr
Change In Net Working Capital	1.34Cr	3.32Cr	-3.44Cr	15Cr	-28Cr
Net Debt Issued / Repaid	-73.89L	-87.93L	-9L	-3L	9L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-8.97	-0.56	15.71	-12.49	46.39
Return on Total Capital	-10.09	-0.62	17.38	-14.35	57.77
Return On Equity %	-14.13	-1.42	25.02	-18.24	71.44
Return on Common Equity	-14.13	-1.42	25.02	-18.24	71.44
Margin Analysis
Gross Profit Margin %	-114.58	67.6	85.45	89.51	97.04
SG&A Margin	379.34	64.8	40.79	57.84	9.75
EBITDA Margin %	-523.12	-0.77	44.71	-82.06	-
EBITA Margin %	-544.96	-3.46	41.71	-89.22	68.44
EBIT Margin %	-544.96	-3.46	41.71	-89.22	68.44
Income From Continuing Operations Margin %	-466.78	-4.87	37.22	-68.81	51.14
Net Income Margin %	-466.78	-4.87	37.22	-68.81	51.14
Net Avail. For Common Margin %	-466.78	-4.87	37.22	-68.81	51.14
Normalized Net Income Margin	-342.19	-3.04	28.05	-46.03	39.25
Levered Free Cash Flow Margin	-353.02	-14.97	34.24	-112.8	58.06
Unlevered Free Cash Flow Margin	-350.98	-14.81	34.27	-112.8	58.12
Asset Turnover
Asset Turnover	0.03	0.26	0.6	0.22	1.08
Fixed Assets Turnover	0.7	6.65	18.56	4.03	22.26
Receivables Turnover (Average Receivables)	-	-	-	7.21	20.73
Short Term Liquidity
Current Ratio	8.51	11.58	9.22	5.75	4.78
Quick Ratio	8.47	11.47	9.15	5.65	4.76
Operating Cash Flow to Current Liabilities	-1.39	-0.45	2.48	-1.8	2.75
Days Sales Outstanding (Average Receivables)	-	-	-	50.79	17.6
Average Days Payable Outstanding	86.6	81.79	104.58	544.71	229.28
Long Term Solvency
Total Debt/Equity	2.01	1.28	0.48	6.06	2.24
Total Debt / Total Capital	1.97	1.26	0.47	5.71	2.19
LT Debt/Equity	0.99	0.15	0.21	4.59	1.44
Long-Term Debt / Total Capital	0.97	0.15	0.2	4.33	1.41
Total Liabilities / Total Assets	12.15	8.4	11.76	19.5	23.62
EBIT / Interest Expense	-166.89	-14.2	783.41	-	675.34
EBITDA / Interest Expense	-150.76	11.17	873.09	-	682.85
(EBITDA - Capex) / Interest Expense	-155.99	-11.63	850.4	-	677.79
Total Debt / EBITDA	-0.13	1.61	0.02	-0.27	0.03
Net Debt / EBITDA	6.59	-127.34	-3.86	3.67	-1.55
Total Debt / (EBITDA - Capex)	-0.12	-1.54	0.02	-0.24	0.03
Net Debt / (EBITDA - Capex)	6.37	122.36	-3.97	3.23	-1.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-60.64	794.02	168.49	-58.22	676.8
Gross Profit, 1 Yr. Growth %	-296.5	-627.5	239.36	-61.67	742.09
EBITDA, 1 Yr. Growth %	71.04	-98.69	-14.81T	-176.69	-
EBITA, 1 Yr. Growth %	69.9	-94.32	-3.34T	-189.36	-695.88
EBIT, 1 Yr. Growth %	69.9	-94.32	-3.34T	-189.36	-695.88
Earnings From Cont. Operations, 1 Yr. Growth %	74.83	-90.67	-2.15T	-177.24	-677.33
Net Income, 1 Yr. Growth %	74.83	-90.67	-2.15T	-177.24	-677.33
Normalized Net Income, 1 Yr. Growth %	62.47	-92.05	-2.58T	-168.55	-762.51
Diluted EPS Before Extra, 1 Yr. Growth %	74.4	-90.44	-2.09T	-177.39	-674.75
Accounts Receivable, 1 Yr. Growth %	-	-	-	31.83T	70.86
Net Property, Plant and Equip., 1 Yr. Growth %	-15.5	4.49	-11.73	210.42	-14.11
Total Assets, 1 Yr. Growth %	-14.53	-4.39	38.19	-6.27	131.65
Tangible Book Value, 1 Yr. Growth %	-13.07	-0.31	33.11	-14.49	119.8
Common Equity, 1 Yr. Growth %	-13.07	-0.31	33.11	-14.49	119.8
Cash From Operations, 1 Yr. Growth %	52.11	-77.48	-1.08T	-202.14	-552.39
Capital Expenditures, 1 Yr. Growth %	-64.84	190.61	-41.61	257.85	-61.54
Levered Free Cash Flow, 1 Yr. Growth %	29.04	-62.3	-712.39	-237.63	-503.92
Unlevered Free Cash Flow, 1 Yr. Growth %	29.42	-62.46	-719.27	-237.5	-504.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-69.88	87.58	389.93	5.91	80.15
Gross Profit, 2 Yr. CAGR %	-62.63	221.95	323.1	21.87	79.66
EBITDA, 2 Yr. CAGR %	8.49	-85	42.97	962.14	-
EBITA, 2 Yr. CAGR %	12.2	-68.95	35.55	437.83	130.75
EBIT, 2 Yr. CAGR %	12.2	-68.95	35.55	437.83	130.75
Earnings From Cont. Operations, 2 Yr. CAGR %	16.36	-59.61	38.34	298	111.17
Net Income, 2 Yr. CAGR %	16.36	-59.61	38.34	298	111.17
Normalized Net Income, 2 Yr. CAGR %	11.52	-64.06	40.28	311.94	113.1
Diluted EPS Before Extra, 2 Yr. CAGR %	16.63	-59.18	37.98	292.66	110.9
Accounts Receivable, 2 Yr. CAGR %	288.6	-	-71.97	-	2.24T
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.67	-6.04	-3.96	65.53	63.28
Total Assets, 2 Yr. CAGR %	-12.9	-9.6	14.94	13.81	47.35
Tangible Book Value, 2 Yr. CAGR %	-10.04	-6.91	15.2	6.69	37.1
Common Equity, 2 Yr. CAGR %	-10.04	-6.91	15.2	6.69	37.1
Cash From Operations, 2 Yr. CAGR %	-34.48	-41.47	48.49	216.21	114.96
Capital Expenditures, 2 Yr. CAGR %	15.96	1.09	30.27	44.56	17.31
Levered Free Cash Flow, 2 Yr. CAGR %	-45.78	-30.07	52.19	190.32	134.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	-46	-30.12	52.7	191.8	134.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-67.12	-6.75	111.4	115.65	105.78
Gross Profit, 3 Yr. CAGR %	-62.92	-9.68	227.65	98.61	132.12
EBITDA, 3 Yr. CAGR %	-34.96	-75.08	51.95	16.17	-
EBITA, 3 Yr. CAGR %	-33.97	-58.5	46.15	17.97	456.52
EBIT, 3 Yr. CAGR %	-33.97	-58.5	46.15	17.97	456.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-32.04	-49.82	49.57	13.92	350.54
Net Income, 3 Yr. CAGR %	-32.04	-49.82	49.57	13.92	350.54
Normalized Net Income, 3 Yr. CAGR %	-34.04	-53.76	47.32	10.49	382.64
Diluted EPS Before Extra, 3 Yr. CAGR %	-32.02	-49.34	49.19	13.79	345.83
Accounts Receivable, 3 Yr. CAGR %	-	-	-	192.7	-
Net Property, Plant and Equip., 3 Yr. CAGR %	53.73	-1.71	-7.98	42	33.01
Total Assets, 3 Yr. CAGR %	-13.62	-10.15	4.14	7.39	44.23
Tangible Book Value, 3 Yr. CAGR %	-8.15	-6.91	4.88	4.3	35.75
Common Equity, 3 Yr. CAGR %	-8.15	-6.91	4.88	4.3	35.75
Cash From Operations, 3 Yr. CAGR %	-11.12	-54.1	49.69	31.08	256.3
Capital Expenditures, 3 Yr. CAGR %	1.02	57.51	-15.81	82.44	-7.03
Levered Free Cash Flow, 3 Yr. CAGR %	-32.92	-51.88	44.29	47.17	223
Unlevered Free Cash Flow, 3 Yr. CAGR %	-32.98	-52.08	44.76	47.45	224.22
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-24.64	7.91	-3.13	-1.88	98.29
Gross Profit, 5 Yr. CAGR %	-22.53	10.73	-1.82	1.82	164.57
EBITDA, 5 Yr. CAGR %	15.88	-41.61	-10.81	13.11	-
EBITA, 5 Yr. CAGR %	17.41	-19.87	-11.96	15.63	75.44
EBIT, 5 Yr. CAGR %	17.41	-19.87	-11.96	15.63	75.44
Earnings From Cont. Operations, 5 Yr. CAGR %	15.78	-5.91	-9.69	14.89	71.7
Net Income, 5 Yr. CAGR %	15.78	-5.91	-9.69	14.89	71.7
Normalized Net Income, 5 Yr. CAGR %	13.64	-10.14	-10.8	10.9	70.76
Diluted EPS Before Extra, 5 Yr. CAGR %	8.3	-10.21	-9.77	14.92	71.35
Accounts Receivable, 5 Yr. CAGR %	34.96	-	-	227.84	-
Net Property, Plant and Equip., 5 Yr. CAGR %	43	37.82	27.36	21.08	15.75
Total Assets, 5 Yr. CAGR %	4.86	-5.53	-3.17	-1.24	19.65
Tangible Book Value, 5 Yr. CAGR %	66.98	4.33	0.56	-1.69	16.74
Common Equity, 5 Yr. CAGR %	66.98	4.33	0.56	-1.69	16.74
Cash From Operations, 5 Yr. CAGR %	-26.95	-25.22	9.13	-0.67	73
Capital Expenditures, 5 Yr. CAGR %	8.13	29.89	11.83	52.19	-3.86
Levered Free Cash Flow, 5 Yr. CAGR %	-32.69	-24.95	-6.81	-1.19	75.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	-32.77	-25.06	-6.74	-1.23	75.6